[Assessing the coxibs]

Duodecim. 2003;119(21):2071-7.
[Article in Finnish]
No abstract available

Publication types

  • Review

MeSH terms

  • Animals
  • Blood Coagulation / drug effects
  • Cyclooxygenase 1
  • Cyclooxygenase 2
  • Cyclooxygenase 2 Inhibitors
  • Cyclooxygenase Inhibitors / adverse effects*
  • Cyclooxygenase Inhibitors / therapeutic use
  • Digestive System / drug effects
  • Endothelium, Vascular / drug effects
  • Endothelium, Vascular / physiopathology
  • Humans
  • Isoenzymes / antagonists & inhibitors
  • Kidney / drug effects
  • Kidney / physiopathology
  • Membrane Proteins
  • Patient Selection
  • Prostaglandin-Endoperoxide Synthases

Substances

  • Cyclooxygenase 2 Inhibitors
  • Cyclooxygenase Inhibitors
  • Isoenzymes
  • Membrane Proteins
  • Cyclooxygenase 1
  • Cyclooxygenase 2
  • PTGS1 protein, human
  • PTGS2 protein, human
  • Prostaglandin-Endoperoxide Synthases